Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review MHG Fonseca, GP Furtado, MRL Bezerra, LQ Pontes, CFC Fernandes International journal of biological macromolecules 119, 306-311, 2018 | 28 | 2018 |
Epigenetic reprogramming in cancer: From diagnosis to treatment PMS Costa, SLA Sales, DP Pinheiro, LQ Pontes, SSA Maranhão, ... Frontiers in cell and developmental biology 11, 1116805, 2023 | 26 | 2023 |
Progress on phage display technology: tailoring antibodies for cancer immunotherapy RKA França, IC Studart, MRL Bezerra, LQ Pontes, AMA Barbosa, ... Viruses 15 (9), 1903, 2023 | 14 | 2023 |
Ethnopharmacological and Genetic Study on the Treatment of Mental Disorders: a Systematic Review CKT Lima, LQ Pontes, LG Pinho, MRL Bezerra, W da Silva Barroso, ... International Archives of Medicine 8, 2015 | 2 | 2015 |
Ultrastructural aspects of cranial and peripheric nerves of cronically diabetic and malnourished rats: a short biochemical panorama A de Oliveira Saraiva, LQ Pontes, LG Pinho, MRL Bezerra, HA Braga, ... International Archives of Medicine 8, 2015 | 1 | 2015 |
Kinetics characterization of a low immunogenic recombinant l-asparaginase from Phaseolus vulgaris with cytotoxic activity against leukemia cells JG da Silva Gomes, LC Brandão, DP Pinheiro, LQ Pontes, RF Carneiro, ... International Journal of Biological Macromolecules 275, 133731, 2024 | | 2024 |
Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19 PAQ Rossi, R Gomes, TC do Nascimento Salazar, EML Barros, ... Journal of Physical Activity and Health 1 (aop), 1-9, 2024 | | 2024 |
Reconversion of rituximab’s scFv into FvFc: a suitable format to understand CDR mutations of monoclonal antibodies MR Bezerra, PEG Saraiva Filho, LQ Pontes, DP Pinheiro, RPS Araújo, ... Instituto de Tecnologia em Imunobiológicos, 2024 | | 2024 |
Proposição de fragmentos de anticorpo de domínio variável (scFv) anti-CD20 para o desenvolvimento de bispecíficos t-cell engager (BiTE) LQ Pontes | | 2023 |
CAR-T Cells and Other Related Technologies MRL Bezerra, LQ Pontes, IC Studart, B de Sousa Lima, GP Furtado The Golden Guide to Oncologic Pharmacy, 281-314, 2022 | | 2022 |
Selection of human antibody fragments by phage display: development of new anti-CD19 molecules for CAR-T cell therapies MRL Bezerra, LQ Pontes, AQ Maranhão, GP Furtado Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021 | | 2021 |
Construção, por desenho racional, e caracterização de variantes de afinidade da região variável do anticorpo monoclonal Rituximabe LQ Pontes | | 2019 |
Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody LQ Pontes, MRL Bezerra, MHG Fonseca, MR Lourenzoni, GP Furtado Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019 | | 2019 |
Construction of a scFv library using directed evolution for rituximab-based therapies: using phage display towards antibody affinity maturation MRL Bezerra, AQ Maranhao, IC Studart, LQ Pontes, MHG Fonseca, ... Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019 | | 2019 |